☆ 4.6 Article

Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell line

CLINICAL AND EXPERIMENTAL MEDICINE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Decrease post-transplant relapse using donor-derived expanded NK-cells

Stefan O. Ciurea et al.

Summary: In this phase I/II clinical trial, high doses of mb-IL21 ex vivo expanded donor-derived NK cells were administered to 25 patients with myeloid malignancies undergoing haploidentical stem-cell transplantation. The results showed a significant decrease in the relapse rate and improved disease-free survival compared to the control group, with a particular benefit in patients without donor-specific anti-HLA antibodies. The administration of expanded NK cells post-transplantation was safe and led to NK cell-dominant immune reconstitution, preserved T-cell reconstitution, and better clinical outcomes.

LEUKEMIA (2022)

添加到收藏夹

Review Oncology

Natural killer cells in antitumour adoptive cell immunotherapy

Tamara J. Laskowski et al.

Summary: This review provides an overview of NK cell-based immunotherapies, discussing strategies to increase NK cell cytotoxicity and persistence and highlighting the current challenges and future opportunities for the design of next-generation NK cell therapies.

NATURE REVIEWS CANCER (2022)

添加到收藏夹

Review Oncology

NK cell-based cancer immunotherapy: from basic biology to clinical development

Sizhe Liu et al.

Summary: NK cells, as a specialized immune effector cell type, play a critical role in immune activation against abnormal cells. Unlike T cell activation, NK cell activation is governed by interactions between NK receptors and target cells, leading to significant attention in cancer immunotherapy. Many efforts are focused on developing and engineering NK cell-based cancer immunotherapy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer

Dristhi Ragoonanan et al.

Summary: In this Consensus Statement, updated comprehensive recommendations are provided for managing toxicities from cancer immunotherapies in children, adolescents and young adults. The recommendations emphasize the importance of minimizing toxicities, adopting age-based and discipline-specific management criteria, and early critical care assessment. Advocacy for increased inclusion of young cancer patients in well-designed clinical trials is also highlighted.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy

Adrian Fernandez et al.

Summary: NK cells have shown promise in cancer immunotherapy, and an NK cell activation-expansion process was optimized and validated on a clinical scale in this study. Various cell culture media and artificial antigen presenting cells were used to obtain GMP-grade NK cells suitable for clinical use. NK cells derived from PBMC yielded higher purity and total cell numbers compared to CD45RA(+) cells, and the use of K562mbIL21-41BBL cells resulted in the highest fold expansion and NK purity.

CANCERS (2021)

添加到收藏夹

Article Hematology

Adoptive immunotherapy with double-bright (CD56bright/CD16bright) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof-of-concept study

Lucia Silla et al.

Summary: In this study, repeated infusions of expanded NK cells showed promising outcomes in high-risk patients with relapsed or refractory AML, with high overall response and complete response rates. No dose-limiting toxicities or infusion-related complications were observed, indicating the safety and feasibility of this treatment approach.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Review Oncology

Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer

Irina Buckle et al.

Summary: The discovery of immune checkpoints has revolutionized cancer therapy, leading to early clinical success with monoclonal antibodies against PD-1 and CTLA-4. While traditionally focused on T cells, there is now increasing evidence that immune checkpoint molecules also play a role in regulating Natural Killer (NK) cell responses to cancer. This review provides insights into the potential therapeutic targets among NK cell inhibitory receptors and their implications for cancer treatment.

CANCERS (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

NK cells for cancer immunotherapy

Noriko Shimasaki et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

添加到收藏夹

Article Medicine, General & Internal

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Enli Liu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Cell & Tissue Engineering

Evaluation of serum -free media formulations in feeder cell stimulated expansion of natural killer cells

Jena E. Moseman et al.

CYTOTHERAPY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways

Yan Yang et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

添加到收藏夹

Review Immunology

Cellular therapy: Adoptive immunotherapy with expanded natural killer cells

Dean A. Lee

IMMUNOLOGICAL REVIEWS (2019)

添加到收藏夹

Review Oncology

Natural killer cells: a review of biology, therapeutic potential and challenges in treatment of solid tumors

Khalil Choucair et al.

FUTURE ONCOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells

Evelyn O. Ojo et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Article Immunology

Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped Lentivector

Aurelien B. L. Colamartino et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Oncology

Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia

M. Vela et al.

CANCER LETTERS (2018)

添加到收藏夹

Article Immunology

An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells

Nicole A. P. Lieberman et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Analysis of NK cell clones obtained using interleukin-2 and gene-modified K562 cells revealed the ability of senescent NK cells to lose CD57 expression and start expressing NKG2A

Maria A. Streltsova et al.

PLOS ONE (2018)

添加到收藏夹

Review Oncology

Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials

Wade Chun-Wai Suen et al.

CANCER INVESTIGATION (2018)

添加到收藏夹

Review Immunology

The More, The Better: Do the Right Thing For natural Killer immunotherapy in Acute Myeloid Leukemia

Sarah Parisi et al.

FRONTIERS IN IMMUNOLOGY (2017)

添加到收藏夹

Article Oncology

Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours

Mira M. Shenouda et al.

BREAST CANCER RESEARCH (2017)

添加到收藏夹

Article Hematology

Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma

Nina Shah et al.

BRITISH JOURNAL OF HAEMATOLOGY (2017)

添加到收藏夹

Article Oncology

Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients

Antonio Curti et al.

CLINICAL CANCER RESEARCH (2016)

添加到收藏夹

Article Hematology

Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study

Inpyo Choi et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)

添加到收藏夹

Article Oncology

Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy

Yin Liu et al.

CLINICAL CANCER RESEARCH (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells

Cecele J. Denman et al.

PLOS ONE (2012)

添加到收藏夹

Article Hematology

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset

Sandra Lopez-Verges et al.

BLOOD (2010)

添加到收藏夹

Article Oncology

Allogeneic natural killer cells for refractory lymphoma

Veronika Bachanova et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)

添加到收藏夹

Article Immunology

Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK cells but also from CD16- CD56dim NK cells

E. Takahashi et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)

添加到收藏夹

Article Hematology

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

JS Miller et al.

BLOOD (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.